- Towards an understanding of the side effects of anti-HIV drugs using Caenorhabditis elegans
- Award date
- 12 February 2016
- Number of pages
- Document type
- PhD thesis
- Faculty of Science (FNWI)
- Swammerdam Institute for Life Sciences (SILS)
Since the discovery of HIV-1 as a cause for AIDS, many antiretroviral drugs - such as the nucleoside reverse transcriptase inhibitors (NRTIs) and the protease inhibitors (PIs) - have been developed to target viral replication. The therapeutic use of a combination of drugs, more commonly known as Highly Active Anti-Retroviral Therapy (HAART), has significantly improved the quality and length of patient lives.
Overshadowing this success, however, is the problem that HIV-1 infected patients are afflicted with drug induced adverse events, some of which can be life threatening. Most adverse events seem to be related to tissues with high-energy demand and have predominantly been found to be caused by mitochondrial toxicity.
In this thesis the nematode Caenorhabditis elegans is used as a model system to study the adverse side effects of HIV-1 antiretroviral medicines administered alone or in combination. Using an array of established and novel molecular techniques, drugs that have similar chemical structure and modes of action are shown to each have distinct toxicity profiles. Evidence is shown in support of an earlier proposal that there are modes to NRTI toxicity beyond the polymerase-γ theory and a novel hypothesis that NRTIs cause premature and accelerated aging is assessed. Interestingly, the observed mitochondrial dysfunction and toxicity phenotypes of both NRTIs and PIs could be attenuated by antioxidants.
Taken together, this project has endeavoured to shed some light on the mechanisms behind HIV drug toxicity and ultimately benefit the development of new, effective, and less toxic compounds.
- Research conducted at: Universiteit van Amsterdam
Thesis (complete) (Embargo until 12 February 2018)
Chapter 3: HIV-1 Nucleoside Reverse Transcription Inhibitors inhibit mitochondrial respiratory chain function and induce a mitohormesis like prolonged longevity in C. elegans (Embargo until 12 February 2018)
Chapter 4: A RNAseq genome wide analysis of antiretroviral thymidine analogue effects in C. elegans (Embargo until 12 February 2018)
Chapter 5: Protease Inhibitor HIV-1 antiretroviral therapy causes immediate mitochondrial respiratory chain dysfunction that can be attenuated by antioxidants (Embargo until 12 February 2018)
Chapter 6: Analysis of Nucleoside Reverse Transcription Inhibitor and Protease Inhibitor combination therapy in C. elegans (Embargo until 12 February 2018)
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.